SCHEMBL3427156

SCHEMBL3427156

CC(C)(C)[Si](C)(C)OCCNC(=O)OCc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.63
LMNA P02545 1/20 0.63
L3MBTL1 Q9Y468 2/20 0.56
MAPT P10636 2/20 0.55
HTT P42858 1/20 0.53
TGM2 P21980 1/20 0.48
KEAP1 Q14145 2/20 0.47
NFE2L2 Q16236 2/20 0.47
SLC1A3 P43003 1/20 0.45
SLC1A1 P43005 1/20 0.45
IDO1 P14902 1/20 0.45
ATM Q13315 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1895297 0.92 HTT (0.58) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL5724218 0.85 SMN1; SMN2 (0.60) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL19438891 0.82 CHRNB2 (0.57) SMN1; SMN2L3MBTL1HTTKMT2A
SCHEMBL30938203 0.82 SMN1; SMN2 (0.44) SMN1; SMN2LMNAHTT
SCHEMBL31480636 0.82 LTA4H (0.46) SMN1; SMN2LMNAL3MBTL1MAPTCA1
SCHEMBL26129282 0.81 NPC1 (0.47)
SCHEMBL16757577 0.81 LTA4H (0.44) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL6240402 0.81 HTT (0.56) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL28948064 0.80 LMNA (0.44) SMN1; SMN2LMNAL3MBTL1MAPTHTT
SCHEMBL28948076 0.80 LMNA (0.44) SMN1; SMN2LMNAL3MBTL1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025061148-A1 HETEROARYL COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2025-03-27 WO disclosed
WO-2015197872-A1 DERIVATIVES OF OSW-1 AND USE THEREOF FOR THE TREATMENT OF CANCER PIERRE FABRE MEDICAMENT (FR) 2015-12-30 WO disclosed
US-8481502-B2 Antibacterial aminoglycoside analogs ACHAOGEN, INC. (US) 2013-07-09 US disclosed
WO-2010027280-A1 NITROBENZINDOLES AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2010-03-11 WO disclosed